TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36053970

Group type: EXPERIMENTAL
Intervention: edaravone-edaravone (EE)
Number of subjects: 304

Group type: COMPARATOR
Intervention: edaravone-placebo (EP)
Number of subjects: 304

Group type: COMPARATOR
Intervention: placebo-edaravone (PE)
Number of subjects: 304
Study: 35578315

Group type: EXPERIMENTAL
Intervention: Self-management of sedative therapy with dexmedetomidine
Number of subjects: 190

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 190
Study: 34431819

Group type: EXPERIMENTAL
Intervention: 1,064 nm laser alone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 2,940 nm laser alone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combined treatment (1,064 nm and 2,940 nm lasers)
Number of subjects: 20
Study: 32483870

Group type: EXPERIMENTAL
Intervention: Dialectical behaviour therapy (DBT)
Number of subjects: 14
Study: 33992255

Group type: EXPERIMENTAL
Intervention: Coplanar arrangement of continuous shortwave diathermy (CSWD)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Contraplanar arrangement of continuous shortwave diathermy (CSWD)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Longitudinal arrangement of continuous shortwave diathermy (CSWD)
Number of subjects: 18
Study: 33028390

Group type: EXPERIMENTAL
Intervention: Comprehensive Nano stemless total shoulder arthroplasty
Number of subjects: 122

Group type: COMPARATOR
Intervention: Comprehensive stemmed total shoulder arthroplasty
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 122
Study: 34423832

Group type: EXPERIMENTAL
Intervention: 2 mg/kg methylprednisolone
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study: 34347776

Group type: EXPERIMENTAL
Intervention: Cluster of young patients without comorbidities for community-acquired pneumonia (n = 1,603)
Number of subjects: 6046

Group type: EXPERIMENTAL
Intervention: Cluster of young patients without comorbidities for meningitis or encephalitis (n = 149)
Number of subjects: 6046

Group type: EXPERIMENTAL
Intervention: Cluster of elderly patients with COPD for bronchial infection (n = 243)
Number of subjects: 6046

Group type: EXPERIMENTAL
Intervention: Cluster of elderly patients with comorbidities and organ failures (n = 1,094)
Number of subjects: 6046

Group type: EXPERIMENTAL
Intervention: Cluster of patients after surgery with nosocomial infection (n = 623)
Number of subjects: 6046

Group type: EXPERIMENTAL
Intervention: Cluster of young patients with immunosuppressive conditions (n = 338)
Number of subjects: 6046
Study: 34936023

Group type: EXPERIMENTAL
Intervention: Antenatal pelvic floor muscle training (PFMT) during pregnancy for 12 weeks
Number of subjects: 298

Group type: COMPARATOR
Intervention: Standard antenatal care during pregnancy
Number of subjects: 298
Study: 34682317

Group type: EXPERIMENTAL
Intervention: Personal Isolation Training (PIT)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Detraining (DT)
Number of subjects: 11
Study: 32874098

Group type: EXPERIMENTAL
Intervention: Indoor Cycling (IC)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cross-Country Skiing (XCS)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Alpine Skiing (AS)
Number of subjects: 18
Study: 33544984

Group type: EXPERIMENTAL
Intervention: 37% carbamide peroxide (CP)
Number of subjects: 45

Group type: COMPARATOR
Intervention: 35% hydrogen peroxide (HP)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both CP and HP
Number of subjects: 45
Study: 32881359

Group type: EXPERIMENTAL
Intervention: Bromhexine hydrochloride (BRH) tablets, 32 mg t.i.d. for 14 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (routine treatment according to China's Novel Coronavirus Pneumonia Diagnosis and Treatment Plan)
Number of subjects: 18
Study: 32032087

Group type: EXPERIMENTAL
Intervention: Integrative care (usual trauma care plus additional resources, psychosocial and movement strategies)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Integrative care
Number of subjects: 99

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 99
Study: 35118740

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture (AA) treatment for 8 weeks
Number of subjects: 75

Group type: COMPARATOR
Intervention: Sham auricular point acupuncture (control)
Number of subjects: 75
Study: 34360391

Group type: EXPERIMENTAL
Intervention: Social aspects (relationship with neighbours, satisfaction with the neighbourhood)
Number of subjects: 1973

Group type: EXPERIMENTAL
Intervention: Density of agglomeration (inner city vs rural areas)
Number of subjects: 1973

Group type: EXPERIMENTAL
Intervention: Noise sensitivity
Number of subjects: 1973

Group type: EXPERIMENTAL
Intervention: Residential satisfaction
Number of subjects: 1973
Study: 32488378

Group type: EXPERIMENTAL
Intervention: Using the Patient Concerns Inventory (PCI)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Not using the Patient Concerns Inventory (PCI)
Number of subjects: 288
Study: 35279258

Group type: EXPERIMENTAL
Intervention: CAP-1002 (1·5 × 10^8 CDCs)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 35986259

Group type: EXPERIMENTAL
Intervention: WELLBASED intervention programme for 12 months
Number of subjects: 875

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 875
Study: 34390762

Group type: EXPERIMENTAL
Intervention: Omarigliptin (once-weekly DPP-4 inhibitor)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Once-daily DPP-4 inhibitors (control)
Number of subjects: 36
Study: 32448677

Group type: EXPERIMENTAL
Intervention: Visual training (40 hours)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Auditory training (40 hours)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Both training groups
Number of subjects: 79
Study: 35831736

Group type: EXPERIMENTAL
Intervention: Aqueous extract of seed of broccoli (AESB)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 33837380

Group type: EXPERIMENTAL
Intervention: Exercise intervention (EX)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 120
Study: 33950795

Group type: EXPERIMENTAL
Intervention: 3D printed models of the canine heart (3DM)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Video guide to echocardiographic anatomy alongside 3D printed models (3DM)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Video only (VO)
Number of subjects: 31
Study: 34157970

Group type: EXPERIMENTAL
Intervention: Bilateral Pecto-intercostal Fascial Block (PIFB)
Number of subjects: 108

Group type: COMPARATOR
Intervention: No nerve block (SALI group)
Number of subjects: 108
Study: 33396403

Group type: EXPERIMENTAL
Intervention: Dietary intake measured through 24 hDR; energy intake for 24–47 months: 4906.2 kJ (girls), 4997.9 kJ (boys); for 48–60 months: 5936.4 kJ (girls), 5621.2 kJ (boys); p = 0.038
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Food frequency questionnaire used to calculate food variety and food group diversity scores; low fruit and vegetable consumption: 24–47 months; 63.8 g (girls), 69.5 g (boys); 48–60 months; 68.3 g (girls), 74.4 g (boys); p = 0.037 (24–47 months), p = 0.038 (48–60 months)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Anthropometric measurements and WHO indicators; stunting noted in 7% (24–47 months) and 20% (48–60 months); p = 0.012
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Anthropometric measurements; overweight in 8% (24–47 months) and 17% (48–60 months) for girls, 17% (24–47 months) and 13% (48–60 months) for boys; p = 0.041
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Blood samples collected to determine serum retinol levels; low serum retinol (<0.070 μmol/L) found in 9.1% of boys (24–47 months), 8% (girls), and 7.4% (boys) (48–60 months)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Blood samples collected to determine haemoglobin levels; low haemoglobin (<11.0 g/dL) found in 50.0% (girls) and 30.4% (boys) (24–47 months), 8.6% (girls) and 39.3% (boys) (48–60 months)
Number of subjects: 116
Study: 35379911

Group type: EXPERIMENTAL
Intervention: Enhanced cleaning and disinfecting protocol
Number of subjects: 15814

Group type: COMPARATOR
Intervention: Control schools cleaning as usual
Number of subjects: 15814
Study: 33334634

Group type: EXPERIMENTAL
Intervention: Text message intervention (DTEXT)
Number of subjects: 395
Study: 32181677

Group type: EXPERIMENTAL
Intervention: Vitamin D3 60,000 IU between 24 and 48 hours postpartum and at 6, 10, and 14 weeks (total 240,000 IU)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Vitamin D3 60,000 IU
Number of subjects: 132
Study: 35235720

Group type: EXPERIMENTAL
Intervention: Brexpiprazole (2-4 mg/d for short-term studies; 1-4 mg/d for long-term studies)
Number of subjects: 831

Group type: EXPERIMENTAL
Intervention: Brexpiprazole (1-4 mg/d)
Number of subjects: 831

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 831
Study: 33883422

Group type: EXPERIMENTAL
Intervention: Magnetic sphincter augmentation (MSA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fundoplication
Number of subjects: 0
Study: 33318150

Group type: EXPERIMENTAL
Intervention: IV metoprolol (2×5 mg bolus)
Number of subjects: 683

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 683

Group type: EXPERIMENTAL
Intervention: IV metoprolol
Number of subjects: 683
Study: 34983242

Group type: EXPERIMENTAL
Intervention: Life Line screening (LLS) program
Number of subjects: 588198

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 588198
Study: 33157233

Group type: EXPERIMENTAL
Intervention: Rice flour containing heat‐killed Lactobacillus paracasei CBA L74
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 35080260

Group type: COMPARATOR
Intervention: BRAF V600K mutation
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: BRAF V600E mutation
Number of subjects: 142
Study: 33475935

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration and Exercise Therapy (WBV + E)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Only Exercise Program (OE)
Number of subjects: 24
Study: 33090213

Group type: EXPERIMENTAL
Intervention: Individual counseling intervention
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 126
Study: 35025155

Group type: EXPERIMENTAL
Intervention: Tenderness point group
Number of subjects: 105

Group type: COMPARATOR
Intervention: Intervertebral foramen point group
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Articular process node group
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Overall comparison
Number of subjects: 105
Study: 34031878

Group type: EXPERIMENTAL
Intervention: Seminar-based training
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no seminar)
Number of subjects: 18
Study: 35904770

Group type: EXPERIMENTAL
Intervention: Microsurgical approach (group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional approach (group A)
Number of subjects: 60
Study: 34495376

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (5 mg twice daily)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Aspirin (100 mg every day)
Number of subjects: 179
Study: 32233666

Group type: EXPERIMENTAL
Intervention: Ross strain males and females
Number of subjects: 200

Group type: COMPARATOR
Intervention: Cobb strain males and females
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Feather loss measurement
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Feather weight measurement
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Logistic equations for cumulative losses
Number of subjects: 200
Study: 34893531

Group type: EXPERIMENTAL
Intervention: DPP+HT
Number of subjects: 50

Group type: COMPARATOR
Intervention: DPP only
Number of subjects: 50
Study: 32187098

Group type: EXPERIMENTAL
Intervention: Females in trajectory Group 3 for Mode 1 in the femur
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: Females in trajectory Group 2 for Mode 1 in the femur
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: Females in trajectory Group 2 for Mode 1 in the tibia
Number of subjects: 473

Group type: COMPARATOR
Intervention: Knees with OA in trajectory Group 3 for Mode 1 in the femur
Number of subjects: 473

Group type: COMPARATOR
Intervention: Knees with OA in trajectory Group 2 for Mode 1 in the femur
Number of subjects: 473

Group type: COMPARATOR
Intervention: Knees with OA in Mode 1 in the tibia
Number of subjects: 473
Study: 34849694

Group type: EXPERIMENTAL
Intervention: Powered toothbrush
Number of subjects: 52

Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both manual and powered toothbrushes
Number of subjects: 52
Study: 36157208

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy plus laparoscopic radical hysterectomy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy plus open radical hysterectomy (control group)
Number of subjects: 42
Study: 34937547

Group type: EXPERIMENTAL
Intervention: Short DNA methylation telomere length (DNAmTL)
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: DNAmTL age acceleration
Number of subjects: 292
Study: 32151161

Group type: EXPERIMENTAL
Intervention: Culprit-lesion-only strategy
Number of subjects: 686

Group type: EXPERIMENTAL
Intervention: Multivessel percutaneous coronary intervention
Number of subjects: 686

Group type: COMPARATOR
Intervention: Overall comparison between sexes
Number of subjects: 686
Study: 34998900

Group type: EXPERIMENTAL
Intervention: Salvage radiotherapy (RT)
Number of subjects: 809

Group type: COMPARATOR
Intervention: Palliative chemotherapy (CT)
Number of subjects: 809
Study: 33186507

Group type: EXPERIMENTAL
Intervention: Video chat language samples
Number of subjects: 62

Group type: COMPARATOR
Intervention: In-person language samples
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Transcription reliability
Number of subjects: 62
Study: 33198777

Group type: EXPERIMENTAL
Intervention: Novel prognostic nomogram
Number of subjects: 32474
Study: 34636899

Group type: EXPERIMENTAL
Intervention: Burosumab every 2 weeks (Q2W)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Burosumab every 4 weeks (Q4W)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Burosumab therapy
Number of subjects: 52
Study: 33872197

Group type: EXPERIMENTAL
Intervention: SOC plus fish skin graft applied weekly for up to 12 weeks
Number of subjects: 49

Group type: COMPARATOR
Intervention: Standard of care (SOC) using collagen alginate dressing
Number of subjects: 49

Group type: COMPARATOR
Intervention: SOC using collagen alginate dressing
Number of subjects: 49
Study: 36151527

Group type: EXPERIMENTAL
Intervention: Surveillance with abbreviated MRI
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 34509820

Group type: EXPERIMENTAL
Intervention: Modified US FOTO model
Number of subjects: 1211

Group type: EXPERIMENTAL
Intervention: Modified UK National PROMs model
Number of subjects: 1211

Group type: EXPERIMENTAL
Intervention: Keele Model 1
Number of subjects: 1211

Group type: EXPERIMENTAL
Intervention: Keele Model 2
Number of subjects: 1211
Study: 36182812

Group type: EXPERIMENTAL
Intervention: Vagus Nerve Stimulation (VNS) paired with rehabilitation using the Vivistim® Paired VNS™ System
Number of subjects: 108
Study: 33893673

Group type: EXPERIMENTAL
Intervention: Five telephone follow-up calls
Number of subjects: 52

Group type: COMPARATOR
Intervention: No telephone calls (control)
Number of subjects: 52
Study: 36173344

Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan plus dapagliflozin
Number of subjects: 120

Group type: COMPARATOR
Intervention: sacubitril/valsartan
Number of subjects: 120
Study: 33410612

Group type: EXPERIMENTAL
Intervention: Mild hypercapnia (Etco2 of 6.5 kPa)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Normocapnia (Etco2 of 5.5 kPa)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both groups pooled together
Number of subjects: 19
Study: 32728703

Group type: EXPERIMENTAL
Intervention: Integrase strand transfer inhibitor (InSTI) resistance testing
Number of subjects: 655

Group type: EXPERIMENTAL
Intervention: Reverse transcriptase inhibitor and PI resistance testing
Number of subjects: 655
Study: 36201186

Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy (AT)
Number of subjects: 386

Group type: COMPARATOR
Intervention: Watchful waiting with supportive care (WWSC)
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Apnea-predominant OSA
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Hypopnea-predominant OSA
Number of subjects: 386
Study: 33609764

Group type: EXPERIMENTAL
Intervention: Visualized Bone Reamer
Number of subjects: 80

Group type: COMPARATOR
Intervention: Traditional Bone Reamer
Number of subjects: 80
Study: 35659196

Group type: EXPERIMENTAL
Intervention: HomeHealth intervention
Number of subjects: 386

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 386
Study: 32389006

Group type: EXPERIMENTAL
Intervention: Comprehensive health education intervention program
Number of subjects: 80
Study: 35947524

Group type: EXPERIMENTAL
Intervention: High-dose dual therapy (HDDT): amoxicillin 750 mg q.i.d. and esomeprazole 40 mg t.i.d.
Number of subjects: 216

Group type: COMPARATOR
Intervention: Amoxicillin and clarithromycin-containing bismuth quadruple therapy (ACBQT): esomeprazole 20 mg, bismuth potassium citrate 2 g, amoxicillin 1 g, and clarithromycin 500 mg; b.i.d.
Number of subjects: 216
Study: 36047662

Group type: EXPERIMENTAL
Intervention: Active HD-tDCS-eTBS
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham HD-tDCS-eTBS
Number of subjects: 24
Study: 32277750

Group type: EXPERIMENTAL
Intervention: Yoga therapy as an adjunct treatment for MUPS
Number of subjects: 0
Study: 35131440

Group type: EXPERIMENTAL
Intervention: Active CPAP treatment
Number of subjects: 98

Group type: COMPARATOR
Intervention: Sham CPAP treatment
Number of subjects: 98
Study: 33934522

Group type: COMPARATOR
Intervention: Prophylactic AMU
Number of subjects: 322

Group type: COMPARATOR
Intervention: Therapeutic AMU
Number of subjects: 322
Study: 35234097

Group type: EXPERIMENTAL
Intervention: pMDI + VMN
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: pMDI + JN
Number of subjects: 0

Group type: COMPARATOR
Intervention: VMN
Number of subjects: 0
Study: 33960071

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation (PMR) exercises, twice weekly for 8 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 45
Study: 34597919

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tofacitinib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Canakinumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydroxychloroquine/Chloroquine
Number of subjects: 0
Study: 34244775

Group type: EXPERIMENTAL
Intervention: Community pharmacists' intention to report ADRs
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Attitude towards ADR reporting
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Subjective norm
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Perceived moral obligation
Number of subjects: 188
Study: 33174467

Group type: EXPERIMENTAL
Intervention: CRMRF (448 kHz capacitive resistive monopolar radiofrequency)
Number of subjects: 45

Group type: COMPARATOR
Intervention: CRMRF placebo
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 45
Study: 35622779

Group type: EXPERIMENTAL
Intervention: Oxidized regenerated cellulose (SurgiGuard®) plus closed suction drainage
Number of subjects: 94

Group type: COMPARATOR
Intervention: Closed suction drainage alone
Number of subjects: 94
Study: 33952876

Group type: EXPERIMENTAL
Intervention: ShotBlocker
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control
Number of subjects: 74
Study: 35152534

Group type: EXPERIMENTAL
Intervention: MRI prognostic score based on serum CA19-9 and three MRI findings (tumour multiplicity, lymph node metastasis, bile duct invasion)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: MRI prognostic score
Number of subjects: 316
Study: 33528862

Group type: EXPERIMENTAL
Intervention: Inhaled nitrous oxide (INO)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: 1% lidocaine
Number of subjects: 314

Group type: COMPARATOR
Intervention: No analgesic
Number of subjects: 314
Study: 35641925

Group type: EXPERIMENTAL
Intervention: Smoking cessation induction video delivered via VR headset during teeth cleaning, brochure about EBTs, and a 4-week text message program
Number of subjects: 376

Group type: COMPARATOR
Intervention: Relaxation video delivered via VR headset during teeth cleaning, the same brochure as INT, and assessment-only text messages
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Smoking cessation induction video delivered via VR headset
Number of subjects: 376

Group type: COMPARATOR
Intervention: Relaxation video delivered via VR headset
Number of subjects: 376
Study: 33464990

Group type: EXPERIMENTAL
Intervention: Positive psychological constructs
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Development of a core set of psychological outcomes
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Randomized trials
Number of subjects: 276
Study: 32534515

Group type: EXPERIMENTAL
Intervention: Chronic Migraine (CM) patients
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Episodic Migraine (EM) patients
Number of subjects: 71

Group type: COMPARATOR
Intervention: Headache-free controls
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: All migraine patients (CM and EM)
Number of subjects: 71
Study: 36818483

Group type: EXPERIMENTAL
Intervention: Nebulized milrinone
Number of subjects: 32

Group type: COMPARATOR
Intervention: IV milrinone
Number of subjects: 32
Study: 33004727

Group type: EXPERIMENTAL
Intervention: Group Motivational Therapy (GMT)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Individualised Motivational Therapy (IMT)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Negative control group
Number of subjects: 108
Study: 36284336

Group type: EXPERIMENTAL
Intervention: Ensemble algorithm for identifying CRT reports
Number of subjects: 5000

Group type: COMPARATOR
Intervention: Individual algorithms (SVM and CNN)
Number of subjects: 5000
Study: 32467406

Group type: EXPERIMENTAL
Intervention: Palliative consultations
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Floating hospice referrals
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Floating hospice discharge
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Palliative care consults
Number of subjects: 400